Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Palliative Care × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Lung Neoplasms 2 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Motor Activity 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cervical Cancer Screening 1 Advanced Malignant Solid Neoplasm 1

Interventions

Rituximab 8 Lenalidomide 5 Cyclophosphamide 5 ibrutinib 3 Vincristine 3 Prednisone 3 CT-P10 3 venetoclax 2 orelabrutinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Doxorubicin 2 zanubrutinib 1 tafasitamab 1 prednylidene 1 polatuzumab vedotin 1 obinutuzumab 1 ianalumab 1 fludarabine phosphate 1 fludarabine 1 deltacortene 1 cc-486 1 acalabrutinib 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Radiotherapy 1 R-CHOP protocol 1 Pharmacogenomic Testing 1 Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡